The Lancet Neurology in conversation with
Varighed i alt:
13 h 19 min
The future of Alzheimer’s disease: blood biomarkers, brain imaging, and screening the cognitively unimpaired
The Lancet Neurology in conversation with
28:49
Marjo van der Knaap on vanishing white matter
The Lancet Neurology in conversation with
17:27
Jan D Lùˆnemann and Christian Münz on Epstein–Barr virus and multiple sclerosis
The Lancet Neurology in conversation with
15:45
Hal Dietz discusses the role of genetics in spinal CSF leaks
The Lancet Neurology in conversation with
16:23
Tony Schapira on GBA1 Parkinson's disease
The Lancet Neurology in conversation with
26:05
Henry Brodaty and Alice Powell on cognitive resilience and ageing
The Lancet Neurology in conversation with
23:11
Niklas Mattsson-Carlgren on the use of biomarkers in the diagnosis and stratification of Alzheimer’s disease
The Lancet Neurology in conversation with
16:06
Cristina Tassorelli on migraine prevention
The Lancet Neurology in conversation with
24:01
Inga Zerr and Simon Mead on advances in prion diseases
The Lancet Neurology in conversation with
30:11
Julia Greenland on azathioprine for early Parkinson’s disease
The Lancet Neurology in conversation with
15:06
Ian McKeith on dementia with dementia with Lewy bodies
The Lancet Neurology in conversation with
16:54
Ask Nordestgaard on long-term stroke risk in women
The Lancet Neurology in conversation with
11:48
Shiv Saidha on recent updates in the diagnosis of multiple sclerosis
The Lancet Neurology in conversation with
29:58
Michael Rafii on Down syndrome-related Alzheimer’s disease
The Lancet Neurology in conversation with
23:04
Amit Bar-Or on fenebrutinib for relapsing multiple sclerosis
The Lancet Neurology in conversation with
09:03
Marte-Helene Bjørk on reproductive risks in people with epilepsy
The Lancet Neurology in conversation with
21:03
Geoff Manley on a new classification system for traumatic brain injury
The Lancet Neurology in conversation with
25:57
Wayne Feng on stroke rehabilitation using brain stimulation and constraint-induced movement therapy
The Lancet Neurology in conversation with
20:15
Marialuisa Gandolfi on the management of chronic pain in Parkinson’s disease
The Lancet Neurology in conversation with
13:06
Michael Tymianski on neuroprotection in stroke
The Lancet Neurology in conversation with
25:40
Elizabeth Finger on oxytocin for apathy in frontotemporal dementia
The Lancet Neurology in conversation with
19:06
The Lancet Neurology Editors on advances in neurology in 2024
The Lancet Neurology in conversation with
18:23
Florian Krismer and Elizabeth Coon on multiple system atrophy
The Lancet Neurology in conversation with
18:07
Suvankar Pal on the motor neuron disease trial MND-SMART
The Lancet Neurology in conversation with
18:42
Jorge Correale and Lilyana Amezcua on differential diagnosis of multiple sclerosis
The Lancet Neurology in conversation with
19:52
Alex Iranzo on sleep and Parkinson’s disease
The Lancet Neurology in conversation with
17:37
Adrian Owen on detecting awareness after acute brain injury
The Lancet Neurology in conversation with
18:11
Glenn Nielsen on specialist physiotherapy for people with functional motor disorder
The Lancet Neurology in conversation with
16:21
Sanjay Sisodiya on climate change and brain health
The Lancet Neurology in conversation with
21:41
Jacqueline French and Jacob Pellinen on the diagnosis of epilepsy
The Lancet Neurology in conversation with
24:21
Jaimie Steinmetz, Theo Vos, Katrin Seeher and Tarun Dua on the global burden of disorders affecting the nervous system
The Lancet Neurology in conversation with
26:11
Giovanni Frisoni on biomarker-based diagnosis of neurocognitive disorders
The Lancet Neurology in conversation with
13:12
Marianne Chapleau and Gil Rabinovici on posterior cortical atrophy
The Lancet Neurology in conversation with
22:38
Cecilia Åkerlund and David Nelson on prognosis of traumatic brain injury
The Lancet Neurology in conversation with
19:17
Rustam Al-Shahi Salman on the effects of oral anticoagulation in people with atrial fibrillation after spontaneous intracranial haemorrhage
The Lancet Neurology in conversation with
25:02
Njideka Okubadejo and Mie Rizig on Parkinson’s disease in African and African admixed populations
The Lancet Neurology in conversation with
27:27
Anthony Feinstein on a trial of cognitive rehabilitation and exercise in people with progressive multiple sclerosis
The Lancet Neurology in conversation with
15:35
William Jagust on amyloid β and cognition
The Lancet Neurology in conversation with
14:29
Stephen Strittmatter on a first-in-human trial for treating chronic cervical spinal cord injury
The Lancet Neurology in conversation with
15:27
Benzi Kluger, Claire Creutzfeldt, and Malenna Sumrall on palliative care for individuals with neurological diseases
The Lancet Neurology in conversation with
18:12
